Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Futamura

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Nephron|February 22, 2023
Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term RemissionAzusa Kobayashi, Asami Takeda, Hibiki Shinjo, et al.
Transplantation Direct|June 3, 2017
Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of <i>Pneumocystis jirovecii</i> Pneumonia in Kidney Transplant RecipientsNorihiko Goto, Ai Takahashi-Nakazato, Kenta Futamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2018
The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trialMakoto Tsujita, Tomoki Kosugi, Norihiko Goto, et al.
Frontiers in Immunology|January 26, 2026
Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplantTakahisa Hiramitsu, Yuki Shimamoto, Tomoki Himeno, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 8, 2021
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled TrialMakoto Tsujita, Yohei Doi, Yoshitsugu Obi, et al.
Kidney International Reports|May 6, 2024
Impact of Age 70 years or Older on Donors for Living-Donor Kidney TransplantationTakahisa Hiramitsu, Tomoki Himeno, Yuki Hasegawa, et al.
Frontiers in Immunology|April 26, 2021
Clinical Significance of Shared T Cell Epitope Analysis in Early <i>De Novo</i> Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope AnalysisToshihide Tomosugi, Kenta Iwasaki, Shintaro Sakamoto, et al.
Clinical Transplantation|August 10, 2017
Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatmentManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Human Immunology|April 4, 2018
Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejectionTakayuki Yamamoto, Kenta Iwasaki, Kenta Murotani, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled studyYohei Doi, Makoto Tsujita, Takayuki Hamano, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Nephron|February 22, 2023
Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term RemissionAzusa Kobayashi, Asami Takeda, Hibiki Shinjo, et al.
Transplantation Direct|June 3, 2017
Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of <i>Pneumocystis jirovecii</i> Pneumonia in Kidney Transplant RecipientsNorihiko Goto, Ai Takahashi-Nakazato, Kenta Futamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2018
The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trialMakoto Tsujita, Tomoki Kosugi, Norihiko Goto, et al.
Frontiers in Immunology|January 26, 2026
Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplantTakahisa Hiramitsu, Yuki Shimamoto, Tomoki Himeno, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 8, 2021
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled TrialMakoto Tsujita, Yohei Doi, Yoshitsugu Obi, et al.
Kidney International Reports|May 6, 2024
Impact of Age 70 years or Older on Donors for Living-Donor Kidney TransplantationTakahisa Hiramitsu, Tomoki Himeno, Yuki Hasegawa, et al.
Frontiers in Immunology|April 26, 2021
Clinical Significance of Shared T Cell Epitope Analysis in Early <i>De Novo</i> Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope AnalysisToshihide Tomosugi, Kenta Iwasaki, Shintaro Sakamoto, et al.
Clinical Transplantation|August 10, 2017
Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatmentManabu Okada, Yoshihiko Watarai, Kenta Iwasaki, et al.
Human Immunology|April 4, 2018
Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejectionTakayuki Yamamoto, Kenta Iwasaki, Kenta Murotani, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 10, 2021
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled studyYohei Doi, Makoto Tsujita, Takayuki Hamano, et al.
Pageof 7